Present the main changes and implications of the new Price and Reimbursement dossier (P&R).
Provide practical knowledge for the P&R dossier building based on new AIFA guidelines, published in December 2020, providing in addition useful tools to strategically address possible negotiation issues at AIFA level.
- Introduction and Overview of the new P&R Dossier
- Focus on the Section E of the P&R Dossier
- Operational implications for the P&R dossier drafting and for the development and presentation of the economic assessments.
- Fulvio Luccini
- Dario Lidonnici
- Pierluigi Russo
WHO IT IS FOR
Pharmaceutical company professionals who work in the Pricing, Market Access, HTA, Regulatory Affairs or Business Intelligence field.
The setting of the course is based on interactive teaching which, through practical exercises, favors the interaction and exchange of knowledge between the teacher and the participants. Each training session will be carried out with the help of teaching material prepared by the teachers, in order to consolidate the knowledge acquired. The teaching material will be made available in electronic format at the end of the course.
Discounts are available for multiple registrations to the same course by the same company.
N.B. Registration is valid upon payment of the registration fee by bank transfer
IBAN: IT62R0344001613000000134000 - BIC: BDBDIT22- Account holder: MA Provider srl
The replacement of the registered participant will always be allowed.
Confirmation of registration is required within 7 days from the start date of the course
50% of the total amount will be returned within 7 days from the start date of the course, while the full amount will be withheld from the 6th day.
THE ACTIVATION OF THE WEBINAR IS SUBJECT TO ACHIEVEMENT OF THE MINIMUM NUMBER OF PARTICIPANTS REQUIRED (n° 7 REGISTERED)